Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial prophylaxis for extracorporeal shock wave lithotripsy (SWL)
2021-001486-21Phase 4Completed
- Sponsor
- University of Helsinki
- Start
- Jul 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofloxacin in nephrolithiasis and urinary tract infection (UTI) (2 arms), sponsored by University of Helsinki. Primary endpoint: Composite infectious outcome after SWL. Started Jul 2021; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
nephrolithiasisurinary tract infection (UTI)
Beyond the preview
Go deeper on 2021-001486-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001486-21.